We transiently transfected C3H10T1/2 cells with HSPA5 siRNA using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA) in Opti-MEM medium (Invitrogen), according to the manufacturer’s instructions. The sequences of HSPA5 siRNA are as follows: Forward, 5’-AAGGUUACCCAUGCAGUUGTT-3’ and reverse, 5’-AGAUUCAGCAACUGGUUAAAGTT-3’. Universal Non-targeting Control siRNA was considered and used as the control for non-sequence-specific effects. The capability of siRNA knockdown was evaluated by Western blotting. Each experiment was performed in triplicates.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.